Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-19

FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for abiraterone acetate from Mylan Pharmaceuticals, authorizing a generic version to be marketed. Abiraterone acetate is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)